{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T21:38:36Z","timestamp":1790717916679,"version":"4.1.0"},"reference-count":164,"publisher":"Oxford University Press (OUP)","issue":"13","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81170086"],"award-info":[{"award-number":["81170086"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81270184"],"award-info":[{"award-number":["81270184"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2016M602368"],"award-info":[{"award-number":["2016M602368"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,11,1]]},"DOI":"10.1093\/cvr\/cvx130","type":"journal-article","created":{"date-parts":[[2017,6,29]],"date-time":"2017-06-29T11:21:35Z","timestamp":1498735295000},"page":"1538-1550","source":"Crossref","is-referenced-by-count":60,"title":["Insights into innate immune signalling in controlling cardiac remodelling"],"prefix":"10.1093","volume":"113","author":[{"given":"Yaxing","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuchang District, Wuhan 430060, People\u2019s Republic of China;"},{"name":"Institute of Model Animal of Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"},{"name":"Medical Research Institute, School of Medicine, Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zan","family":"Huang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuchang District, Wuhan 430060, People\u2019s Republic of China;"},{"name":"Institute of Model Animal of Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"},{"name":"Medical Research Institute, School of Medicine, Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"},{"name":"College of Life Sciences, Wuhan University, Wuhan 430072, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongliang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Cardiology, Renmin Hospital of Wuhan University, Jiefang Road 238, Wuchang District, Wuhan 430060, People\u2019s Republic of China;"},{"name":"Institute of Model Animal of Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"},{"name":"Medical Research Institute, School of Medicine, Wuhan University, Donghu Road 115, Wuchang District, Wuhan 430071, People\u2019s Republic of China;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2017,7,3]]},"reference":[{"key":"key\n\t\t\t\t20180328142143_cvx130-B1","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1161\/CIRCULATIONAHA.113.001878","article-title":"Pathological ventricular remodeling: mechanisms: part 1 of 2","volume":"128","author":"Burchfield","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1056\/NEJMra072139","article-title":"Cardiac plasticity","volume":"358","author":"Hill","year":"2008","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1161\/CIRCULATIONAHA.113.001879","article-title":"Pathological ventricular remodeling: therapies: part 2 of 2","volume":"128","author":"Xie","year":"2013","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B4","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.tcm.2012.12.006","article-title":"HDAC-dependent ventricular remodeling","volume":"23","author":"Xie","year":"2013","journal-title":"Trends Cardiovasc Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B5","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1146\/annurev-immunol-032414-112240","article-title":"Innate immune pattern recognition: a cell biological perspective","volume":"33","author":"Brubaker","year":"2015","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.bbadis.2014.04.030","article-title":"Interferon regulatory factors: at the crossroads of immunity, metabolism, and disease","volume":"1852","author":"Zhao","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B7","doi-asserted-by":"crossref","first-page":"5457","DOI":"10.1111\/bph.12881","article-title":"The interferon regulatory factors as novel potential targets in the treatment of cardiovascular diseases","volume":"172","author":"Zhang","year":"2015","journal-title":"Br J Pharmacol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1161\/HYPERTENSIONAHA.115.04898","article-title":"Interferon regulatory factor signalings in cardiometabolic diseases","volume":"66","author":"Zhang","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B9","doi-asserted-by":"crossref","first-page":"4102","DOI":"10.1074\/jbc.M609503200","article-title":"Site-specific Lys-63-linked tumor necrosis factor receptor-associated factor 6 auto-ubiquitination is a critical determinant of I kappa B kinase activation","volume":"282","author":"Lamothe","year":"2007","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.bbrc.2004.09.070","article-title":"The coiled-coil domain of TRAF6 is essential for its auto-ubiquitination","volume":"324","author":"Yang","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B11","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.molcel.2004.08.008","article-title":"TAB2 and TAB3 activate the NF-kappaB pathway through binding to polyubiquitin chains","volume":"15","author":"Kanayama","year":"2004","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B12","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1038\/35085597","article-title":"TAK1 is a ubiquitin-dependent kinase of MKK and IKK","volume":"412","author":"Wang","year":"2001","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nri3111","article-title":"The role of ubiquitylation in immune defence and pathogen evasion","volume":"12","author":"Jiang","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B14","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.molcel.2006.03.026","article-title":"Activation of IKK by TNFalpha requires site-specific ubiquitination of RIP1 and polyubiquitin binding by NEMO","volume":"22","author":"Ea","year":"2006","journal-title":"Mol Cell"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/ncb1384","article-title":"Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]","volume":"8","author":"Wu","year":"2006","journal-title":"Nat Cell Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B16","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1038\/nature08247","article-title":"Direct activation of protein kinases by unanchored polyubiquitin chains","volume":"461","author":"Xia","year":"2009","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B17","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1038\/ni.1819","article-title":"Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines","volume":"11","author":"Tseng","year":"2010","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B18","doi-asserted-by":"crossref","first-page":"4304","DOI":"10.4049\/jimmunol.171.8.4304","article-title":"Toll\/IL-1 receptor domain-containing adaptor inducing IFN-beta (TRIF) associates with TNF receptor-associated factor 6 and TANK-binding kinase 1, and activates two distinct transcription factors, NF-kappa B and IFN-regulatory factor-3, in the Toll-like receptor signaling","volume":"171","author":"Sato","year":"2003","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B19","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nature04374","article-title":"Critical role of TRAF3 in the Toll-like receptor-dependent and -independent antiviral response","volume":"439","author":"Oganesyan","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B20","doi-asserted-by":"crossref","first-page":"3970","DOI":"10.4049\/jimmunol.1401614","article-title":"A role for APPL1 in TLR3\/4-dependent TBK1 and IKKepsilon activation in macrophages","volume":"194","author":"Chau","year":"2015","journal-title":"J Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B21","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1038\/ni.2369","article-title":"C-type lectin receptors orchestrate antifungal immunity","volume":"13","author":"Hardison","year":"2012","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B22","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.immuni.2011.11.015","article-title":"Syk kinase-coupled C-type lectin receptors engage protein kinase C-sigma to elicit Card9 adaptor-mediated innate immunity","volume":"36","author":"Strasser","year":"2012","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B23","doi-asserted-by":"crossref","first-page":"e1001259.","DOI":"10.1371\/journal.ppat.1001259","article-title":"Selective C-Rel activation via Malt1 controls anti-fungal T(H)-17 immunity by dectin-1 and dectin-2","volume":"7","author":"Gringhuis","year":"2011","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B24","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1084\/jem.20082818","article-title":"Dectin-2 is a Syk-coupled pattern recognition receptor crucial for Th17 responses to fungal infection","volume":"206","author":"Robinson","year":"2009","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B25","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/nature04926","article-title":"Card9 controls a non-TLR signalling pathway for innate anti-fungal immunity","volume":"442","author":"Gross","year":"2006","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B26","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1146\/annurev-immunol-031210-101352","article-title":"Signaling by myeloid C-type lectin receptors in immunity and homeostasis","volume":"30","author":"Sancho","year":"2012","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B27","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.coviro.2015.01.004","article-title":"RIG-I-like receptor regulation in virus infection and immunity","volume":"12","author":"Chan","year":"2015","journal-title":"Curr Opin Virol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B28","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.cell.2010.04.018","article-title":"Peroxisomes are signaling platforms for antiviral innate immunity","volume":"141","author":"Dixit","year":"2010","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.cell.2011.06.041","article-title":"MAVS forms functional prion-like aggregates to activate and propagate antiviral innate immune response","volume":"146","author":"Hou","year":"2011","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B30","doi-asserted-by":"crossref","first-page":"e00785.","DOI":"10.7554\/eLife.00785","article-title":"MAVS recruits multiple ubiquitin E3 ligases to activate antiviral signaling cascades","volume":"2","author":"Liu","year":"2013","journal-title":"Elife"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B31","doi-asserted-by":"crossref","first-page":"140.","DOI":"10.1186\/1471-2148-12-140","article-title":"The mammalian PYHIN gene family: phylogeny, evolution and expression","volume":"12","author":"Cridland","year":"2012","journal-title":"BMC Evol Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B32","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1126\/science.aaf7532","article-title":"The DNA-sensing AIM2 inflammasome controls radiation-induced cell death and tissue injury","volume":"354","author":"Hu","year":"2016","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B33","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.chom.2011.04.008","article-title":"IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection","volume":"9","author":"Kerur","year":"2011","journal-title":"Cell Host Microbe"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B34","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1126\/science.1232458","article-title":"Cyclic GMP-AMP synthase is a cytosolic DNA sensor that activates the type I interferon pathway","volume":"339","author":"Sun","year":"2013","journal-title":"Science"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B35","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1038\/ni.1932","article-title":"IFI16 is an innate immune sensor for intracellular DNA","volume":"11","author":"Unterholzner","year":"2010","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B36","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1152\/physrev.00009.2014","article-title":"NOD-like receptors: versatile cytosolic sentinels","volume":"95","author":"Motta","year":"2015","journal-title":"Physiol Rev"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B37","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/sj.emboj.7601962","article-title":"A critical role of RICK\/RIP2 polyubiquitination in Nod-induced NF-kappaB activation","volume":"27","author":"Hasegawa","year":"2008","journal-title":"Embo J"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B38","doi-asserted-by":"crossref","first-page":"e1000500.","DOI":"10.1371\/journal.ppat.1000500","article-title":"NOD2, RIP2 and IRF5 play a critical role in the type I interferon response to Mycobacterium tuberculosis","volume":"5","author":"Pandey","year":"2009","journal-title":"PLoS Pathog"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B39","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1038\/ni1426","article-title":"The adaptor protein CARD9 is required for innate immune responses to intracellular pathogens","volume":"8","author":"Hsu","year":"2007","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B40","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.cub.2009.06.038","article-title":"ITCH K63-ubiquitinates the NOD2 binding protein, RIP2, to influence inflammatory signaling pathways","volume":"19","author":"Tao","year":"2009","journal-title":"Curr Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B41","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1038\/nri.2016.58","article-title":"Inflammasomes: mechanism of assembly, regulation and signalling","volume":"16","author":"Broz","year":"2016","journal-title":"Nat Rev Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.immuni.2016.06.020","article-title":"Post-translational modification control of innate immunity","volume":"45","author":"Liu","year":"2016","journal-title":"Immunity"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B43","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMra043430","article-title":"Inflammation, atherosclerosis, and coronary artery disease","volume":"352","author":"Hansson","year":"2005","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B44","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.lfs.2014.01.062","article-title":"Innate immunity and cardiomyocytes in ischemic heart disease","volume":"100","author":"Lin","year":"2014","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B45","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1093\/cvr\/cvs018","article-title":"The innate immune response in reperfused myocardium","volume":"94","author":"Timmers","year":"2012","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1038\/nrcardio.2011.38","article-title":"Innate immune signaling in cardiac ischemia","volume":"8","author":"Arslan","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1161\/ATVBAHA.107.140723","article-title":"Toll-like receptors 2-deficient mice are protected against postischemic coronary endothelial dysfunction","volume":"27","author":"Favre","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B48","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1161\/CIRCULATIONAHA.109.880187","article-title":"Myocardial ischemia\/reperfusion injury is mediated by leukocytic toll-like receptor-2 and reduced by systemic administration of a novel anti-toll-like receptor-2 antibody","volume":"121","author":"Arslan","year":"2010","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B49","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1161\/01.CIR.0000112575.66565.84","article-title":"Reduced myocardial ischemia-reperfusion injury in toll-like receptor 4-deficient mice","volume":"109","author":"Oyama","year":"2004","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B50","doi-asserted-by":"crossref","first-page":"e000683.","DOI":"10.1161\/JAHA.113.000683","article-title":"Role of extracellular RNA and TLR3-Trif signaling in myocardial ischemia-reperfusion injury","volume":"3","author":"Chen","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B51","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1042\/CS20140444","article-title":"Toll-like receptor 5 deficiency exacerbates cardiac injury and inflammation induced by myocardial ischaemia-reperfusion in the mouse","volume":"129","author":"Parapanov","year":"2015","journal-title":"Clin Sci"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B52","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bbadis.2012.08.008","article-title":"CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia\/reperfusion injury: involving activation of PI3K\/Akt signaling","volume":"1832","author":"Cao","year":"2013","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B53","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.lfs.2016.02.039","article-title":"NOD2 contributes to myocardial ischemia\/reperfusion injury by regulating cardiomyocyte apoptosis and inflammation","volume":"149","author":"Liu","year":"2016","journal-title":"Life Sci"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B54","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s10495-015-1089-1","article-title":"Activation of NOD1 by DAP contributes to myocardial ischemia\/reperfusion injury via multiple signaling pathways","volume":"20","author":"Yang","year":"2015","journal-title":"Apoptosis"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B55","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1159\/000356618","article-title":"NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice","volume":"32","author":"Li","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B56","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1093\/cvr\/cvp055","article-title":"Pharmacological postconditioning effect of muramyl dipeptide is mediated through RIP2 and TAK1","volume":"83","author":"Sicard","year":"2009","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B57","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1161\/CIRCULATIONAHA.110.982777","article-title":"Inflammasome activation of cardiac fibroblasts is essential for myocardial ischemia\/reperfusion injury","volume":"123","author":"Kawaguchi","year":"2011","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B58","doi-asserted-by":"crossref","first-page":"19725","DOI":"10.1073\/pnas.1108586108","article-title":"The inflammasome promotes adverse cardiac remodeling following acute myocardial infarction in the mouse","volume":"108","author":"Mezzaroma","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ijcard.2016.02.043","article-title":"Inhibition of the NLRP3 inflammasome limits the inflammatory injury following myocardial ischemia-reperfusion in the mouse","volume":"209","author":"Toldo","year":"2016","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/FJC.0000000000000247","article-title":"Pharmacologic inhibition of the NLRP3 inflammasome preserves cardiac function after ischemic and nonischemic injury in the mouse","volume":"66","author":"Marchetti","year":"2015","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B61","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/FJC.0000000000000053","article-title":"A novel pharmacologic inhibitor of the NLRP3 inflammasome limits myocardial injury after ischemia-reperfusion in the mouse","volume":"63","author":"Marchetti","year":"2014","journal-title":"J Cardiovasc Pharmacol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B62","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2119\/molmed.2014.00034","article-title":"Interleukin-18 as a therapeutic target in acute myocardial infarction and heart failure","volume":"20","author":"O'Brien","year":"2014","journal-title":"Mol Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B63","doi-asserted-by":"crossref","first-page":"H1025","DOI":"10.1152\/ajpheart.00795.2013","article-title":"Interleukin-18 mediates interleukin-1-induced cardiac dysfunction","volume":"306","author":"Toldo","year":"2014","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B64","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1113\/expphysiol.2012.069831","article-title":"Interleukin-1beta blockade improves cardiac remodelling after myocardial infarction without interrupting the inflammasome in the mouse","volume":"98","author":"Toldo","year":"2013","journal-title":"Exp Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B65","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ijcard.2014.09.148","article-title":"Nlrp3 plays no role in acute cardiac infarction due to low cardiac expression","volume":"177","author":"Jong","year":"2014","journal-title":"Int J Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B66","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/j.bbrc.2015.12.051","article-title":"NLRP3 inflammasome activation during myocardial ischemia reperfusion is cardioprotective","volume":"469","author":"Sandanger","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B67","doi-asserted-by":"crossref","first-page":"e40643.","DOI":"10.1371\/journal.pone.0040643","article-title":"Deletion of the innate immune NLRP3 receptor abolishes cardiac ischemic preconditioning and is associated with decreased Il-6\/STAT3 signaling","volume":"7","author":"Zuurbier","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B68","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1038\/ni.3202","article-title":"The receptor NLRP3 is a transcriptional regulator of TH2 differentiation","volume":"16","author":"Bruchard","year":"2015","journal-title":"Nat Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B69","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1016\/j.yjmcc.2012.01.021","article-title":"MyD88 mediated inflammatory signaling leads to CaMKII oxidation, cardiac hypertrophy and death after myocardial infarction","volume":"52","author":"Singh","year":"2012","journal-title":"J Mol Cell Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B70","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/CIRCULATIONAHA.109.865956","article-title":"Survival and cardiac remodeling after myocardial infarction are critically dependent on the host innate immune interleukin-1 receptor-associated kinase-4 signaling: a regulator of bone marrow-derived dendritic cells","volume":"120","author":"Maekawa","year":"2009","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B71","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/cvr\/cvu044","article-title":"MicroRNA-125b protects against myocardial ischaemia\/reperfusion injury via targeting p53-mediated apoptotic signalling and TRAF6","volume":"102","author":"Wang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B72","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/cvr\/cvs356","article-title":"Increased expression of microRNA-146a decreases myocardial ischaemia\/reperfusion injury","volume":"97","author":"Wang","year":"2013","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B73","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.jhep.2015.08.021","article-title":"Targeting TRAF3 signaling protects against hepatic ischemia\/reperfusions injury","volume":"64","author":"Hu","year":"2016","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B74","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1161\/CIRCHEARTFAILURE.109.899732","article-title":"The cytoprotective effects of tumor necrosis factor are conveyed through tumor necrosis factor receptor-associated factor 2 in the heart","volume":"3","author":"Burchfield","year":"2010","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B75","doi-asserted-by":"crossref","first-page":"e000662.","DOI":"10.1161\/JAHA.113.000662","article-title":"Dysferlin mediates the cytoprotective effects of TRAF2 following myocardial ischemia reperfusion injury","volume":"3","author":"Tzeng","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B76","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1161\/CIRCHEARTFAILURE.114.001635","article-title":"Tumor necrosis factor receptor-associated factor 2 mediates mitochondrial autophagy","volume":"8","author":"Yang","year":"2015","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B77","doi-asserted-by":"crossref","first-page":"H709","DOI":"10.1152\/ajpheart.00186.2005","article-title":"Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats","volume":"290","author":"Matsumoto-Ida","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B78","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1161\/CIRCULATIONAHA.114.011195","article-title":"Transforming growth factor beta-activated kinase 1 signaling pathway critically regulates myocardial survival and remodeling","volume":"130","author":"Li","year":"2014","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B79","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1161\/01.RES.0000083490.43943.85","article-title":"Diverse mechanisms of myocardial p38 mitogen-activated protein kinase activation: evidence for MKK-independent activation by a TAB1-associated mechanism contributing to injury during myocardial ischemia","volume":"93","author":"Tanno","year":"2003","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B80","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nm0897-894","article-title":"In vivo transfection of cis element \u201cdecoy\u201d against nuclear factor-kappaB binding site prevents myocardial infarction","volume":"3","author":"Morishita","year":"1997","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B81","doi-asserted-by":"crossref","first-page":"H466","DOI":"10.1152\/ajpheart.00170.2004","article-title":"Cardiac-specific blockade of NF-kappaB in cardiac pathophysiology: differences between acute and chronic stimuli in vivo","volume":"289","author":"Brown","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B82","doi-asserted-by":"crossref","first-page":"H1089","DOI":"10.1152\/ajpheart.00067.2013","article-title":"Cardiomyocyte-specific p65 NF-kappaB deletion protects the injured heart by preservation of calcium handling","volume":"305","author":"Zhang","year":"2013","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B83","doi-asserted-by":"crossref","first-page":"3075","DOI":"10.1161\/01.CIR.0000108929.93074.0B","article-title":"Nuclear factor-kappaB protects the adult cardiac myocyte against ischemia-induced apoptosis in a murine model of acute myocardial infarction","volume":"108","author":"Misra","year":"2003","journal-title":"Circulation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B84","doi-asserted-by":"crossref","first-page":"H530","DOI":"10.1152\/ajpheart.00549.2006","article-title":"Inhibition of NF-{kappa}B improves left ventricular remodeling and cardiac dysfunction after myocardial infarction","volume":"292","author":"Onai","year":"2007","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B85","doi-asserted-by":"crossref","first-page":"H1337","DOI":"10.1152\/ajpheart.01175.2005","article-title":"Blockade of NF-kappaB improves cardiac function and survival after myocardial infarction","volume":"291","author":"Kawano","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B86","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1161\/CIRCRESAHA.108.189746","article-title":"Targeted deletion of nuclear factor kappaB p50 enhances cardiac remodeling and dysfunction following myocardial infarction","volume":"104","author":"Timmers","year":"2009","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B87","first-page":"210","article-title":"Reprogramming Interferon Regulatory Factor Signaling in Cardiometabolic Diseases","volume":"32","author":"Zhang","year":"2017","journal-title":"Physiology (Bethesda)"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B88","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jacc.2013.11.023","article-title":"In vivo silencing of the transcription factor IRF5 reprograms the macrophage phenotype and improves infarct healing","volume":"63","author":"Courties","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B89","doi-asserted-by":"crossref","first-page":"434.","DOI":"10.1007\/s00395-014-0434-9","article-title":"Interferon regulatory factor 9 is an essential mediator of heart dysfunction and cell death following myocardial ischemia\/reperfusion injury","volume":"109","author":"Zhang","year":"2014","journal-title":"Basic Res Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B90","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1146\/annurev.immunol.26.021607.090400","article-title":"The IRF family transcription factors in immunity and oncogenesis","volume":"26","author":"Tamura","year":"2008","journal-title":"Annu Rev Immunol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B91","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.cytogfr.2016.02.010","article-title":"The unique role of STAT2 in constitutive and IFN-induced transcription and antiviral responses","volume":"29","author":"Blaszczyk","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B92","doi-asserted-by":"crossref","first-page":"392.","DOI":"10.3389\/fphar.2016.00392","article-title":"Hydrogen (H2) Inhibits Isoproterenol-Induced Cardiac Hypertrophy via Antioxidative Pathways","volume":"7","author":"Zhang","year":"2016","journal-title":"Front Pharmacol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B93","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4077\/CJP.2016.BAE365","article-title":"Inhibitory effects of hydrogen on proliferation and migration of vascular smooth muscle cells via down-regulation of mitogen\/activated protein kinase and ezrin-radixin-moesin signaling pathways","volume":"59","author":"Zhang","year":"2016","journal-title":"Chin J Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B94","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1124\/pr.114.010090","article-title":"Toll-like receptors in the vascular system: sensing the dangers within","volume":"68","author":"Goulopoulou","year":"2016","journal-title":"Pharmacol Rev"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B95","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12026-014-8548-6","article-title":"The immune system and hypertension","volume":"59","author":"Singh","year":"2014","journal-title":"Immunol Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B96","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1161\/HYPERTENSIONAHA.111.182154","article-title":"Angiotensin II-induced hypertension is modulated by nuclear factor-kappaBin the paraventricular nucleus","volume":"59","author":"Cardinale","year":"2012","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B97","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1748-1716.2011.02313.x","article-title":"Inflammatory cytokines in paraventricular nucleus modulate sympathetic activity and cardiac sympathetic afferent reflex in rats","volume":"203","author":"Shi","year":"2011","journal-title":"Acta Physiol (Oxf)"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B98","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1161\/HYPERTENSIONAHA.110.150409","article-title":"Brain microglial cytokines in neurogenic hypertension","volume":"56","author":"Shi","year":"2010","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B99","doi-asserted-by":"crossref","first-page":"31.","DOI":"10.1186\/s12974-015-0242-7","article-title":"Toll-like receptor 4 inhibition within the paraventricular nucleus attenuates blood pressure and inflammatory response in a genetic model of hypertension","volume":"12","author":"Dange","year":"2015","journal-title":"J Neuroinflammation"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B100","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/cvr\/cvu067","article-title":"Central blockade of TLR4 improves cardiac function and attenuates myocardial inflammation in angiotensin II-induced hypertension","volume":"103","author":"Dange","year":"2014","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B101","doi-asserted-by":"crossref","first-page":"C596","DOI":"10.1152\/ajpcell.00088.2016","article-title":"Toll-like receptor 4 mutation suppresses hyperhomocysteinemia-induced hypertension","volume":"311","author":"Familtseva","year":"2016","journal-title":"Am J Physiol, Cell Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B102","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/01902140903171610","article-title":"Toll-like receptor 4-deficient mice are resistant to chronic hypoxia-induced pulmonary hypertension","volume":"36","author":"Young","year":"2010","journal-title":"Exp Lung Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B103","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.cardiores.2005.05.025","article-title":"Reduced cardiac hypertrophy in toll-like receptor 4-deficient mice following pressure overload","volume":"68","author":"Ha","year":"2005","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B104","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1016\/j.bbadis.2015.08.013","article-title":"Toll-like receptor 5 deficiency attenuates interstitial cardiac fibrosis and dysfunction induced by pressure overload by inhibiting inflammation and the endothelial-mesenchymal transition","volume":"1852","author":"Liu","year":"2015","journal-title":"Biochim Biophys Acta"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B105","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nature10992","article-title":"Mitochondrial DNA that escapes from autophagy causes inflammation and heart failure","volume":"485","author":"Oka","year":"2012","journal-title":"Nature"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B106","doi-asserted-by":"crossref","first-page":"e000267.","DOI":"10.1161\/JAHA.113.000267","article-title":"Toll-like receptor-2 mediates adaptive cardiac hypertrophy in response to pressure overload through interleukin-1beta upregulation via nuclear factor kappaB activation","volume":"2","author":"Higashikuni","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B107","doi-asserted-by":"crossref","first-page":"9.","DOI":"10.1186\/s12952-016-0050-3","article-title":"Tlr2 deficiency does not limit the development of left ventricular hypertrophy in a model of transverse aortic constriction induced pressure overload","volume":"15","author":"Bualeong","year":"2016","journal-title":"J Negat Results Biomed"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B108","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/cvr\/cvv118","article-title":"NOD1, a new player in cardiac function and calcium handling","volume":"106","author":"Delgado","year":"2015","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B109","doi-asserted-by":"crossref","first-page":"e45260.","DOI":"10.1371\/journal.pone.0045260","article-title":"NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis","volume":"7","author":"Fernandez-Velasco","year":"2012","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B110","doi-asserted-by":"crossref","first-page":"1128","DOI":"10.1038\/labinvest.2013.99","article-title":"NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload","volume":"93","author":"Zong","year":"2013","journal-title":"Lab Invest"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B111","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1113\/expphysiol.2012.068338","article-title":"The Nlrp3 inflammasome promotes myocardial dysfunction in structural cardiomyopathy through interleukin-1beta","volume":"98","author":"Bracey","year":"2013","journal-title":"Exp Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B112","doi-asserted-by":"crossref","first-page":"L378","DOI":"10.1152\/ajplung.00342.2014","article-title":"Absence of the inflammasome adaptor ASC reduces hypoxia-induced pulmonary hypertension in mice","volume":"309","author":"Cero","year":"2015","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B113","doi-asserted-by":"crossref","first-page":"19571","DOI":"10.1074\/jbc.M114.550624","article-title":"Mitochondrial NLRP3 protein induces reactive oxygen species to promote Smad protein signaling and fibrosis independent from the inflammasome","volume":"289","author":"Bracey","year":"2014","journal-title":"J Biol Chem"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B114","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1002\/path.2721","article-title":"Essential role for Smad3 in angiotensin II-induced tubular epithelial-mesenchymal transition","volume":"221","author":"Yang","year":"2010","journal-title":"J Pathol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B115","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1161\/01.RES.0000218782.52610.dc","article-title":"Essential role of Smad3 in angiotensin II-induced vascular fibrosis","volume":"98","author":"Wang","year":"2006","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B116","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0092-8674(03)00432-X","article-title":"Mechanisms of TGF-beta signaling from cell membrane to the nucleus","volume":"113","author":"Shi","year":"2003","journal-title":"Cell"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B117","doi-asserted-by":"crossref","first-page":"H985","DOI":"10.1152\/ajpheart.00720.2005","article-title":"Blockade of MyD88 attenuates cardiac hypertrophy and decreases cardiac myocyte apoptosis in pressure overload-induced cardiac hypertrophy in vivo","volume":"290","author":"Ha","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B118","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCRESAHA.114.302476","article-title":"The long noncoding RNA CHRF regulates cardiac hypertrophy by targeting miR-489","volume":"114","author":"Wang","year":"2014","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1161\/HYPERTENSIONAHA.115.06011","article-title":"Dual activation of TRIF and MyD88 adaptor proteins by angiotensin II evokes opposing effects on pressure, cardiac hypertrophy, and inflammatory gene expression","volume":"66","author":"Singh","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B120","first-page":"20434","article-title":"IRAK4 deficiency promotes cardiac remodeling induced by pressure overload","volume":"8","author":"Yuan","year":"2015","journal-title":"Int J Clin Exp Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B121","doi-asserted-by":"crossref","first-page":"11267.","DOI":"10.1038\/ncomms11267","article-title":"The ubiquitin E3 ligase TRAF6 exacerbates pathological cardiac hypertrophy via TAK1-dependent signalling","volume":"7","author":"Ji","year":"2016","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B122","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1161\/HYPERTENSIONAHA.115.05469","article-title":"Tumor necrosis factor receptor-associated factor 3 is a positive regulator of pathological cardiac hypertrophy","volume":"66","author":"Jiang","year":"2015","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B123","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1161\/CIRCHEARTFAILURE.112.000080","article-title":"Tumor necrosis factor receptor-associated factor 2 signaling provokes adverse cardiac remodeling in the adult mammalian heart","volume":"6","author":"Divakaran","year":"2013","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B124","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.gene.2013.12.052","article-title":"Cardiac-specific Traf2 overexpression enhances cardiac hypertrophy through activating AKT\/GSK3beta signaling","volume":"536","author":"Huang","year":"2014","journal-title":"Gene"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/jcb.24669","article-title":"Disruption of tumor necrosis factor receptor associated factor 5 exacerbates pressure overload cardiac hypertrophy and fibrosis","volume":"115","author":"Bian","year":"2014","journal-title":"J Cell Biochem"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B126","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1038\/75037","article-title":"TAK1 is activated in the myocardium after pressure overload and is sufficient to provoke heart failure in transgenic mice","volume":"6","author":"Zhang","year":"2000","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B127","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1172\/JCI114554","article-title":"The cardiac beta-myosin heavy chain isogene is induced selectively in alpha 1-adrenergic receptor-stimulated hypertrophy of cultured rat heart myocytes","volume":"85","author":"Waspe","year":"1990","journal-title":"J Clin Invest"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B128","doi-asserted-by":"crossref","first-page":"e53412.","DOI":"10.1371\/journal.pone.0053412","article-title":"IKKi deficiency promotes pressure overload-induced cardiac hypertrophy and fibrosis","volume":"8","author":"Dai","year":"2013","journal-title":"PLoS One"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B129","doi-asserted-by":"crossref","first-page":"6668","DOI":"10.1073\/pnas.111155798","article-title":"Activation of NF-kappa B is required for hypertrophic growth of primary rat neonatal ventricular cardiomyocytes","volume":"98","author":"Purcell","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B130","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1161\/CIRCRESAHA.111.260729","article-title":"Interaction between NFkappaB and NFAT coordinates cardiac hypertrophy and pathological remodeling","volume":"110","author":"Liu","year":"2012","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B131","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1093\/cvr\/cvp237","article-title":"NF-kappaB activation is required for adaptive cardiac hypertrophy","volume":"84","author":"Zelarayan","year":"2009","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B132","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1161\/CIRCHEARTFAILURE.114.001297","article-title":"Cardiomyocyte p65 nuclear factor-kappaB is necessary for compensatory adaptation to pressure overload","volume":"8","author":"Javan","year":"2015","journal-title":"Circ Heart Fail"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B133","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.jss.2012.03.003","article-title":"Inhibitory kappa-B kinase-beta inhibition prevents adaptive left ventricular hypertrophy","volume":"178","author":"Andersen","year":"2012","journal-title":"J Surg Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B134","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/cdd.2014.9","article-title":"IRF4 is a novel mediator for neuronal survival in ischaemic stroke","volume":"21","author":"Guo","year":"2014","journal-title":"Cell Death Differ"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B135","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1161\/HYPERTENSIONAHA.111.00614","article-title":"Role of interferon regulatory factor 4 in the regulation of pathological cardiac hypertrophy","volume":"61","author":"Jiang","year":"2013","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B136","doi-asserted-by":"crossref","first-page":"326.","DOI":"10.1007\/s00395-012-0326-9","article-title":"Interferon regulatory factor 3 is a negative regulator of pathological cardiac hypertrophy","volume":"108","author":"Lu","year":"2013","journal-title":"Basic Res Cardiol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B137","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/HYPERTENSIONAHA.113.02653","article-title":"Interferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophy","volume":"63","author":"Jiang","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B138","doi-asserted-by":"crossref","first-page":"3303.","DOI":"10.1038\/ncomms4303","article-title":"IRF8 suppresses pathological cardiac remodelling by inhibiting calcineurin signalling","volume":"5","author":"Jiang","year":"2014","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B139","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/HYPERTENSIONAHA.113.02083","article-title":"Interferon regulatory factor 9 protects against cardiac hypertrophy by targeting myocardin","volume":"63","author":"Jiang","year":"2014","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B140","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1096\/fj.10-174615","article-title":"IRF3 regulates cardiac fibrosis but not hypertrophy in mice during angiotensin II-induced hypertension","volume":"25","author":"Tsushima","year":"2011","journal-title":"Faseb J"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B141","doi-asserted-by":"crossref","first-page":"a016246.","DOI":"10.1101\/cshperspect.a016246","article-title":"Microbial sensing by Toll-like receptors and intracellular nucleic acid sensors","volume":"7","author":"Pandey","year":"2015","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B142","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1161\/CIRCRESAHA.110.226936","article-title":"The emerging role of innate immunity in the heart and vascular system: for whom the cell tolls","volume":"108","author":"Mann","year":"2011","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B143","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1038\/cr.2015.68","article-title":"Metabolic reprogramming in macrophages and dendritic cells in innate immunity","volume":"25","author":"Kelly","year":"2015","journal-title":"Cell Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B144","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1084\/jem.20151570","article-title":"Immunometabolism governs dendritic cell and macrophage function","volume":"213","author":"O'Neill","year":"2016","journal-title":"J Exp Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/nm.3908","article-title":"Inflammasome-independent role of AIM2 in suppressing colon tumorigenesis via DNA-PK and Akt","volume":"21","author":"Wilson","year":"2015","journal-title":"Nat Med"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B146","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1161\/CIRCRESAHA.115.306233","article-title":"TRAF6-mediated SM22alpha K21 ubiquitination promotes G6PD activation and NADPH production, contributing to GSH homeostasis and VSMC survival in vitro and in vivo","volume":"117","author":"Dong","year":"2015","journal-title":"Circ Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B147","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1161\/HYPERTENSIONAHA.116.08192","article-title":"Reprogramming innate immune signaling in cardiometabolic disease","volume":"69","author":"Zhang","year":"2017","journal-title":"Hypertension"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B148","doi-asserted-by":"crossref","first-page":"566","DOI":"10.2337\/db11-0474","article-title":"Hepatic TRAF2 regulates glucose metabolism through enhancing glucagon responses","volume":"61","author":"Chen","year":"2012","journal-title":"Diabetes"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B149","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.jhep.2016.03.006","article-title":"Tumor necrosis factor receptor-associated factor 5 (Traf5) acts as an essential negative regulator of hepatic steatosis","volume":"65","author":"Gao","year":"2016","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B150","doi-asserted-by":"crossref","first-page":"10592.","DOI":"10.1038\/ncomms10592","article-title":"Hepatocyte TRAF3 promotes liver steatosis and systemic insulin resistance through targeting TAK1-dependent signalling","volume":"7","author":"Wang","year":"2016","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B151","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/j.jhep.2016.02.002","article-title":"Targeting hepatic TRAF1-ASK1 signaling to improve inflammation, insulin resistance, and hepatic steatosis","volume":"64","author":"Xiang","year":"2016","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B152","doi-asserted-by":"crossref","first-page":"e1467.","DOI":"10.1038\/cddis.2014.411","article-title":"TRAF1 is a key mediator for hepatic ischemia\/reperfusion injury","volume":"5","author":"Zhang","year":"2014","journal-title":"Cell Death Dis"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B153","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1093\/hmg\/ddg018","article-title":"A central role of interferon regulatory factor-1 for the limitation of neointimal hyperplasia","volume":"12","author":"Wessely","year":"2003","journal-title":"Hum Mol Genet"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B154","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.jash.2016.07.005","article-title":"Interferon regulatory factor 1 attenuates vascular remodeling; roles of angiotensin II type 2 receptor","volume":"10","author":"Nakaoka","year":"2016","journal-title":"J Am Soc Hypertens"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B155","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1093\/cvr\/cvu052","article-title":"Interferon regulatory factor 3 protects against adverse neo-intima formation","volume":"102","author":"Zhang","year":"2014","journal-title":"Cardiovasc Res"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B156","doi-asserted-by":"crossref","first-page":"e001309.","DOI":"10.1161\/JAHA.114.001309","article-title":"Interferon regulatory factor 7 protects against vascular smooth muscle cell proliferation and neointima formation","volume":"3","author":"Huang","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B157","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1128\/MCB.01070-13","article-title":"Interferon regulatory factor 8 modulates phenotypic switching of smooth muscle cells by regulating the activity of myocardin","volume":"34","author":"Zhang","year":"2014","journal-title":"Mol Cell Biol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B158","doi-asserted-by":"crossref","first-page":"5160.","DOI":"10.1038\/ncomms6160","article-title":"Interferon regulatory factor 9 is critical for neointima formation following vascular injury","volume":"5","author":"Zhang","year":"2014","journal-title":"Nat Comms"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B159","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.jhep.2014.08.022","article-title":"Interferon regulatory factor 9 is a key mediator of hepatic ischemia\/reperfusion injury","volume":"62","author":"Wang","year":"2015","journal-title":"J Hepatol"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B160","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1002\/hep.26368","article-title":"Interferon regulatory factor 9 protects against hepatic insulin resistance and steatosis in male mice","volume":"58","author":"Wang","year":"2013","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B161","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1002\/hep.26751","article-title":"Interferon regulatory factor 3 constrains IKKbeta\/NF-kappaB signaling to alleviate hepatic steatosis and insulin resistance","volume":"59","author":"Wang","year":"2014","journal-title":"Hepatology"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B162","doi-asserted-by":"crossref","first-page":"E485","DOI":"10.1152\/ajpendo.00505.2012","article-title":"Interferon regulatory factor 7 deficiency prevents diet-induced obesity and insulin resistance","volume":"305","author":"Wang","year":"2013","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B163","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.cmet.2011.02.005","article-title":"Transcriptional control of adipose lipid handling by IRF4","volume":"13","author":"Eguchi","year":"2011","journal-title":"Cell Metab"},{"key":"key\n\t\t\t\t20180328142143_cvx130-B164","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.cell.2014.04.049","article-title":"IRF4 is a key thermogenic transcriptional partner of PGC-1alpha","volume":"158","author":"Kong","year":"2014","journal-title":"Cell"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/cardiovascres\/article-pdf\/113\/13\/1538\/21349842\/cvx130.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T02:33:20Z","timestamp":1719282800000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/113\/13\/1538\/3920520"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7,3]]},"references-count":164,"journal-issue":{"issue":"13","published-online":{"date-parts":[[2017,7,3]]},"published-print":{"date-parts":[[2017,11,1]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvx130","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2017,11]]},"published":{"date-parts":[[2017,7,3]]}}}